journal article·2017-02-17

Synthesis and Characterization of a New Co-Crystal Explosive with High Energy and Good Sensitivity

Han Gao, Wei Jiang, Jie Liu, Gazi Hao, Lei Xiao, Xiang Ke, Teng Chen

Publisher page

Abstract

A new energetic co-crystal consisting of one of the most powerful explosive molecules 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazaisowurtzitane (CL-20) and the military explosive cyclotrimethylenetrinitramine (RDX) was prepared with a simple solvent evaporation method. Scanning electron microscopy (SEM) revealed the morphology of the bar-shaped product, which differed greatly from the morphology of the individual components. Fourier transform infrared spectroscopy (FT-IR), Raman spectroscopy, X-ray diffraction spectrum (XRD), and differential scanning calorimetry (DSC) proved the formation of the co-crystal at the molecular level. The result of mechanical sensitivity test indicated the sensitivity was effectively reduced compared to raw CL-20. Finally, a possible crystallization mechanism was discussed.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Energetic Materials and Combustion · Crystallography and molecular interactions · Thermal and Kinetic Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. 10.1002/anie.v50.3810.1002/anie.v50.38 ↗
2. 10.1021/cg301088210.1021/cg3010882 ↗
3. 10.1021/cg801397t10.1021/cg801397t ↗
4. 10.1021/cg900197210.1021/cg9001972 ↗
5. 10.1021/cg100099w10.1021/cg100099w ↗
6. 10.1021/cg100156a10.1021/cg100156a ↗
7. 10.1021/cg034035x10.1021/cg034035x ↗
8. 10.1021/cg801039j10.1021/cg801039j ↗
9. 10.1021/cg101300n10.1021/cg101300n ↗
10. 10.1002/anie.20130281410.1002/anie.201302814 ↗
11. 10.1021/cg300424510.1021/cg3004245 ↗
12. 10.1002/(ISSN)1521-408710.1002/(ISSN)1521-4087 ↗
13. 10.1080/07370652.2012.71649210.1080/07370652.2012.716492 ↗
14. 10.1016/j.molstruc.2016.01.02710.1016/j.molstruc.2016.01.027 ↗
15. 10.1134/S001050821204015610.1134/S0010508212040156 ↗
16. 10.1016/j.ijpharm.2011.07.03710.1016/j.ijpharm.2011.07.037 ↗
17. 10.1039/C5CE00489F10.1039/C5CE00489F ↗
18. 10.1021/cg900129f10.1021/cg900129f ↗
19. 10.1021/cg101703210.1021/cg1017032 ↗
20. 10.1016/j.jhazmat.2006.06.02710.1016/j.jhazmat.2006.06.027 ↗
21. 10.1021/ja057939a10.1021/ja057939a ↗
22. 10.1002/prep.20070022310.1002/prep.200700223 ↗
23. 10.1021/cg049654010.1021/cg0496540 ↗
24. 10.1021/cg049965a10.1021/cg049965a ↗
25. 10.1557/mrs2006.20610.1557/mrs2006.206 ↗
26. 10.1002/prep.20120009310.1002/prep.201200093 ↗
27. 10.1021/cg300955q10.1021/cg300955q ↗